1-6 of 6
Joe Y. Chang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti–PD1-Resistant Lung Tumor Model

Sharareh Niknam, Hampartsoum B. Barsoumian, Jonathan E. Schoenhals, Heather L. Jackson, Niranjan Yanamandra, Mauricio S. Caetano, Ailin Li, Ahmed I. Younes, Alexandra Cadena, Taylor R. Cushman, Joe Y. Chang, Quynh N. Nguyen, Daniel R. Gomez, Adi Diab, John V. Heymach, Patrick Hwu, Maria Angelica Cortez, James W. Welsh
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (22): 5735–5743.
https://doi.org/10.1158/1078-0432.CCR-17-3279
Published: 15 November 2018
View article titled, Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti–PD1-Resistant Lung Tumor Model
Open the PDF for Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti–PD1-Resistant Lung Tumor Model in another window
Includes: Supplementary data
Journal Articles

Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells

Chad Tang, James W. Welsh, Patricia de Groot, Erminia Massarelli, Joe Y. Chang, Kenneth R. Hess, Sreyashi Basu, Michael A. Curran, Maria E. Cabanillas, Vivek Subbiah, Siqing Fu, Apostolia M. Tsimberidou, Daniel Karp, Daniel R. Gomez, Adi Diab, Ritsuko Komaki, John V. Heymach, Padmanee Sharma, Aung Naing, David S. Hong
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (6): 1388–1396.
https://doi.org/10.1158/1078-0432.CCR-16-1432
Published: 14 March 2017
View article titled, Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells
Open the PDF for Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells in another window
Includes: Supplementary data
Journal Articles

Treatment of Radioresistant Stem-Like Esophageal Cancer Cells by an Apoptotic Gene-Armed, Telomerase-Specific Oncolytic Adenovirus

Xiaochun Zhang, Ritsuko Komaki, Li Wang, Bingliang Fang, Joe Y. Chang
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (9): 2813–2823.
https://doi.org/10.1158/1078-0432.CCR-07-1528
Published: 01 May 2008
View article titled, Treatment of Radioresistant Stem-Like Esophageal Cancer Cells by an Apoptotic Gene-Armed, Telomerase-Specific Oncolytic Adenovirus
Open the PDF for Treatment of Radioresistant Stem-Like Esophageal Cancer Cells by an Apoptotic Gene-Armed, Telomerase-Specific Oncolytic Adenovirus in another window
Journal Articles

Radiotherapy Sensitization by Tumor-Specific TRAIL Gene Targeting Improves Survival of Mice Bearing Human Non–Small Cell Lung Cancer

Xiaochun Zhang, Rex Min Cheung, Ritsuko Komaki, Bingliang Fang, Joe Y. Chang
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6657–6668.
https://doi.org/10.1158/1078-0432.CCR-04-2699
Published: 15 September 2005
View article titled, Radiotherapy Sensitization by Tumor-Specific <em>TRAIL</em> Gene Targeting Improves Survival of Mice Bearing Human Non–Small Cell Lung Cancer
Open the PDF for Radiotherapy Sensitization by Tumor-Specific <em>TRAIL</em> Gene Targeting Improves Survival of Mice Bearing Human Non–Small Cell Lung Cancer in another window
Journal Articles

A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non–Small Cell Lung Cancer

Zhongxing Liao, Ritsuko Komaki, Luka Milas, Chen Yuan, Merrill Kies, Joe Y. Chang, Melenda Jeter, Thomas Guerrero, George Blumenschien, Cheryl M. Smith, Frank Fossella, Barry Brown, James D. Cox
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (9): 3342–3348.
https://doi.org/10.1158/1078-0432.CCR-04-1741
Published: 02 May 2005
View article titled, A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non–Small Cell Lung Cancer
Open the PDF for A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non–Small Cell Lung Cancer in another window
Journal Articles

High Mutagen Sensitivity in Peripheral Blood Lymphocytes Predicts Poor Overall and Disease-Specific Survival in Patients with Stage III Non–Small Cell Lung Cancer Treated with Radiotherapy and Chemotherapy

Joe Y. Chang, Ritsuko Komaki, Ryohei Sasaki, Zhongxing Liao, Craig W. Stevens, Charles Lu, Frank V. Fossella, Pamela K. Allen, James D. Cox, Margaret R. Spitz, Xifeng Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (8): 2894–2898.
https://doi.org/10.1158/1078-0432.CCR-04-2176
Published: 18 April 2005
View article titled, High Mutagen Sensitivity in Peripheral Blood Lymphocytes Predicts Poor Overall and Disease-Specific Survival in Patients with Stage III Non–Small Cell Lung Cancer Treated with Radiotherapy and Chemotherapy
Open the PDF for High Mutagen Sensitivity in Peripheral Blood Lymphocytes Predicts Poor Overall and Disease-Specific Survival in Patients with Stage III Non–Small Cell Lung Cancer Treated with Radiotherapy and Chemotherapy in another window